News / Sofinnova Industrial Biotech I raises €106m

Sofinnova Industrial Biotech I raises €106m

🕔 March 15, 2017
 Sol Systems and Nationwide launch fund for solar assets

Sofinnova Partners, a Paris, France-based venture capital firm specialized in life sciences, held the first closing of its latest fund, Sofinnova Industrial Biotech I (Sofinnova IB I), at €106 million (US$112,7 million).

Existing Subscriber?

If you are an existing subscriber please sign in to read this article in full.


IPP Journal Registration

League Tables

IPP Journal accepts project & transaction submissions to ensure that the data we have in our databases is accurate.

Download Submission Form  Download Submission Form


Subscribe to our newsletter and get in your inbox jobs, news and business opportunities.

The Africa Energy Forum (AEF MAURITIUS)
Spring Special Sidebar

Follow us on Twitter

Infrastructure & PPP news

InfraPPP World